Suchergebnisse - "Cagnazzo, Celeste"

PubPharm (6)

1

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer : The MAYA Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Morano, F. | Raimondi, A. | Pagani, F. | +30

2

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients : A prospective study

enthalten in: Cancer medicine | 2018

von Galizia, D. | Milani, A. | Geuna, E. | +16

3

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR

enthalten in: PloS one | 2018

von Peraldo-Neia, C. | Cavalloni, G. | Fenocchio, E. | +15

4

Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer

enthalten in: JAMA oncology | 2016

von Montemurro, F. | Mittica, G. | Cagnazzo, C. | +16

CommentIn: JAMA Oncol. 2016 Apr;2(4):433-4. - PMID 26720842

5

Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study

enthalten in: Cancer | 2013

von Leone, F. | Artale, S. | Marino, D. | +13

6

Biliary tract carcinomas : from chemotherapy to targeted therapy

enthalten in: Critical reviews in oncology/hematology | 2013

von Marino, D. | Leone, F. | Cavalloni, G. | +2

1
[1]